Tags

Type your tag names separated by a space and hit enter

Cannabinoid/anandamide system and schizophrenia: is there evidence for association?

Abstract

Cognitive impairments during psychotic episodes are assumed to be caused not only by one single putative classical neurotransmitter dysfunction but also to be due to an impaired equilibrium of the interaction between different neurobiological generators of cognitive processes. Here, the perceptual abnormalities induced by psychotogenic agents play a major role as tools for understanding model psychoses. The recently discovered cannabinoid receptor system with its endogenous ligand anandamide can be regarded as an extremely relevant regulation system, a dysfunctionality of which may explain at least one subtype of endogenous psychoses. The present paper discusses the possible associations between the endogenous anandamide/cannabinoid system and schizophrenic psychoses. Neuropsychological experiments with the 3-D inversion paradigm were performed in healthy volunteers intoxicated with delta9-Tetrahydrocannabinol (delta9-THC). The 3-D inversion paradigm represents a visual illusion of binocular depth perception. Such an inversion occurs in many cases, especially when objects with a higher degree of familiarity (e.g. photographs of faces) are displayed. It is assumed that cognitive factors override the binocular disparity cues of stereopsis. We tested the hypothesis that, during psychotic and related prepsychotic states, the human CNS is unable to correct implausible perceptual hypotheses. Our study provides evidence of strong similarities between data acquired from patients, suffering from productive schizophrenic psychoses and delta9-THC-intoxicated healthy volunteers, as concerns disturbances in the internal regulation of perceptual processes.

Authors+Show Affiliations

,

Department of Clinical Psychiatry and Psychotherapy, Medical School, Hannover, Germany.

, ,

Source

Pharmacopsychiatry 31 Suppl 2: 1998 Jul pg 110-3

MeSH

Arachidonic Acids
Cannabinoids
Cannabis
Endocannabinoids
Humans
Polyunsaturated Alkamides
Schizophrenia
Schizophrenic Psychology
Time Factors
Visual Perception

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

9754842

Citation

Schneider, U, et al. "Cannabinoid/anandamide System and Schizophrenia: Is There Evidence for Association?" Pharmacopsychiatry, vol. 31 Suppl 2, 1998, pp. 110-3.
Schneider U, Leweke FM, Mueller-Vahl KR, et al. Cannabinoid/anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry. 1998;31 Suppl 2:110-3.
Schneider, U., Leweke, F. M., Mueller-Vahl, K. R., & Emrich, H. M. (1998). Cannabinoid/anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry, 31 Suppl 2, pp. 110-3.
Schneider U, et al. Cannabinoid/anandamide System and Schizophrenia: Is There Evidence for Association. Pharmacopsychiatry. 1998;31 Suppl 2:110-3. PubMed PMID: 9754842.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cannabinoid/anandamide system and schizophrenia: is there evidence for association? AU - Schneider,U, AU - Leweke,F M, AU - Mueller-Vahl,K R, AU - Emrich,H M, PY - 1998/10/1/pubmed PY - 1998/10/1/medline PY - 1998/10/1/entrez SP - 110 EP - 3 JF - Pharmacopsychiatry JO - Pharmacopsychiatry VL - 31 Suppl 2 N2 - Cognitive impairments during psychotic episodes are assumed to be caused not only by one single putative classical neurotransmitter dysfunction but also to be due to an impaired equilibrium of the interaction between different neurobiological generators of cognitive processes. Here, the perceptual abnormalities induced by psychotogenic agents play a major role as tools for understanding model psychoses. The recently discovered cannabinoid receptor system with its endogenous ligand anandamide can be regarded as an extremely relevant regulation system, a dysfunctionality of which may explain at least one subtype of endogenous psychoses. The present paper discusses the possible associations between the endogenous anandamide/cannabinoid system and schizophrenic psychoses. Neuropsychological experiments with the 3-D inversion paradigm were performed in healthy volunteers intoxicated with delta9-Tetrahydrocannabinol (delta9-THC). The 3-D inversion paradigm represents a visual illusion of binocular depth perception. Such an inversion occurs in many cases, especially when objects with a higher degree of familiarity (e.g. photographs of faces) are displayed. It is assumed that cognitive factors override the binocular disparity cues of stereopsis. We tested the hypothesis that, during psychotic and related prepsychotic states, the human CNS is unable to correct implausible perceptual hypotheses. Our study provides evidence of strong similarities between data acquired from patients, suffering from productive schizophrenic psychoses and delta9-THC-intoxicated healthy volunteers, as concerns disturbances in the internal regulation of perceptual processes. SN - 0176-3679 UR - https://www.unboundmedicine.com/medline/citation/9754842/Cannabinoid/anandamide_system_and_schizophrenia:_is_there_evidence_for_association L2 - http://www.diseaseinfosearch.org/result/6442 DB - PRIME DP - Unbound Medicine ER -